The combination of oligo- and polysaccharides and reticulated protein for the control of symptoms in patients with irritable bowel syndrome: Results of a randomised, placebo-controlled, double-blind, parallel group, multicentre clinical trial.
Octavian Alexea, Vlad Bacarea and Nuria Pique. United European Gastroenterol J. 2016 Jun;4(3):455-65. Background: A medical device containing the film-forming agent reticulated protein and a
Gelatin Tannate for Acute Childhood Gastroenteritis: A Randomized, Single-Blind Controlled Trial.
Maurizio Mennini1,Carlo Tolone, Antonella Frassanito, Fabio Midulla3, Salvatore Cucchiare, Marina Aloi. Paediatr Drugs. 2016 Dec 20. doi: 10.1007/s40272-016-0207-z Background: Oral rehydration therapy is the recommended
A new class of non-drug treatments for rhinitis of various origins is gaining momentum. Among them, Xyloglucan stands out as a natural substance with a well-defined mode of action…
A new class of non-drug treatments for rhinitis of various origins is gaining momentum. Among them, Xyloglucan stands out as a natural substance with a
Listado de investigadores
Centros de investigación participantes en el ensayo
clínico con el hidrogel EHO-85
“Advantages of Gel Oral Rehydration Solutions (ORS) for the Management of Acute Diarrhea: An Update”
Piqué N, Miñana-Galbis D, Machlab S. Advantages of Gel Oral Rehydration Solutions (ORS) for the Management of Acute Diarrhea: An Update. Ann Pediatr Child Health
Partner Medexport – Utipro Plus AF – Kazakhstan
Noventure is proud to announce that Medexport has signed an agreement for the distribution of Utipro Plus AF in Kazakhstan We are very grateful for
Partner Medexport – Utipro Plus AF – Kazakhstan
Noventure is proud to announce that Medexport has signed an agreement for the distribution of Utipro Plus AF in Kazakhstan We are very grateful for
Partner Pamex UK
Glad to inform that Noventure partnership with the Irish partner Pamex is growing! We are really happy to announce that Pamex is extending their distribution
Launch of TASECTAN® AF in Denmark
Noventure is glad to announce the launch of TASECTAN® AF in Denmark by its partner company Pharmaforce, thus setting a record time-to-market, after Noventure granted
UTIPRO® PLUS Launched in Denmark
We are pleased to announce the launch of UTIPRO® PLUS, our product for uncomplicated UTIs, in Denmark. The product is commercialized under the brand UrinCUR /
Let's meet in ...
2026, Oct 6-8th
CPHI 2026
2026, June 24
